# Study of Two Digital Therapeutics for the Prevention of Episodic Migraine

> **NCT05853900** · NA · COMPLETED · sponsor: **Click Therapeutics, Inc.** · enrollment: 568 (actual)

## Conditions studied

- Migraine
- Episodic Migraine
- Headache
- Headache, Migraine

## Interventions

- **DEVICE:** ReMMi-D Digital Therapeutic

## Key facts

- **NCT ID:** NCT05853900
- **Lead sponsor:** Click Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-28
- **Primary completion:** 2024-05-07
- **Final completion:** 2024-05-07
- **Target enrollment:** 568 (ACTUAL)
- **Last updated:** 2025-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05853900

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05853900, "Study of Two Digital Therapeutics for the Prevention of Episodic Migraine". Retrieved via AI Analytics 2026-09-09 from https://api.ai-analytics.org/clinical/NCT05853900. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*